Search | Page 8 | Aplastic Anemia and MDS International Foundation

Search

Search results

  1. Treatment options for patients with myelodysplastic syndromes after hypomethylating agent failure

    ... The treatment of patients with myelodysplastic syndromes (MDSs) has hinged primarily on supportive care (ie, blood ...

    Research Article last updated 01/26/2017 - 10:36am.

  2. Prophylactic RhCE and Kell antigen matching: impact on alloimmunization in transfusion-dependent patients with myelodysplastic syndromes

    ... OBJECTIVES: Thirty to 80 per cent of patients with myelodysplastic syndromes (MDS) become transfusion-dependent and are at risk for red ...

    Research Article last updated 02/03/2017 - 11:00am.

  3. Safety and efficacy of azacitidine in elderly patients with intermediate to high-risk myelodysplastic syndromes

    ... January 1, 2017 Myelodysplastic syndromes (MDS) represent a clonal hematopoietic stem cell disorder ...

    Research Article last updated 02/01/2017 - 8:17am.

  4. Therapy-related myelodysplastic syndromes, or are they?

    ... The incidence of therapy-related myelodysplastic syndromes (t-MDS) is increasing as the number of cancer survivors is ...

    Research Article last updated 01/26/2017 - 10:08am.

  5. Recurrent Cytogenetic Abnormalities in Myelodysplastic Syndromes

    ... role in diagnosis, classification, and prognosis of myelodysplastic syndromes (MDS). Some cytogenetic abnormalities are sufficiently ... Bone Marrow Diseases:  myelodysplastic syndromes (MDS) ...

    Research Article last updated 01/26/2017 - 11:01am.

  6. Myelodysplastic syndromes and myelodysplastic/myeloproliferative neoplasms: an update on risk stratification, molecular genetics, and therapeutic approaches including allogeneic hematopoietic stem cell transplantation

    ... May 31, 2015 Myelodysplastic syndromes are a heterogeneous group of clonal hematopoietic stem cell ...

    Research Article last updated 06/22/2015 - 10:15am.

  7. Genetics and Epigenetics of Myelodysplastic Syndromes and Response to Drug Therapy: New Insights

    ... 14, 2016 Myelodysplastic syndromes (MDS) are a heterogeneous group of hematologic neoplasms ocurring ...

    Research Article last updated 02/01/2017 - 8:15am.

  8. Occupational, dietary, and other risk factors for myelodysplastic syndromes in Western Greece

    ... PURPOSE: We have observed an increasing incidence of myelodysplastic syndromes (MDS) in the geographic area of Western Greece during the past ...

    Research Article last updated 02/03/2017 - 10:41am.

  9. Allogeneic Hematopoietic Stem Cell Transplantation is Underutilized in Older Patients with Myelodysplastic Syndromes

    ... transplantation (HCT) is the only curative treatment for myelodysplastic syndrome (MDS). The proportion of MDS patients referred for ... Bone Marrow Diseases:  myelodysplastic syndromes (MDS) ...

    Research Article last updated 04/14/2017 - 9:28am.

  10. Integrating Frailty, Comorbidity, and Quality of Life in the Management of Myelodysplastic Syndromes.

    ... January 1, 2017 Myelodysplastic syndromes (MDS) are a group of acquired hematopoietic stem cell disorders ...

    Research Article last updated 01/24/2017 - 7:25am.